×
Diurnal Mood Variation in Outpatients With Major Depressive Disorder: Implications for DSM-V From an Analysis of the Sequenced Treatment Alternatives to Relieve Depression Study Data PDF
$ 40.00
Diurnal Mood Variation in Outpatients With Major Depressive Disorder: Implications for DSM-V From an Analysis of the Sequenced Treatment Alternatives to Relieve Depression Study Data PDF quantity
$ 40.00
×
Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study PDF
$ 40.00
Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study PDF quantity
$ 40.00
×
Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder: Evaluation of Incidence and Screening Methods. PDF
$ 40.00
Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder: Evaluation of Incidence and Screening Methods. PDF quantity
$ 40.00
×
Development of Neuroleptic Malignant Syndrome After Administration of Clozapine and Electroconvulsive Therapy in a Patient With Schizophrenia PDF
$ 40.00
Development of Neuroleptic Malignant Syndrome After Administration of Clozapine and Electroconvulsive Therapy in a Patient With Schizophrenia PDF quantity
$ 40.00
×
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF
$ 40.00
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
